NI CMO Independence
COVID-19 Inquiry · Module 2: Core Decision-Making · Issued 20 November 2025 · Addressed to: Department of Health NI
Government responseUK Government: Not applicable (Mar 2026)Northern Ireland Executive: Accepted (Mar 2026)
DeliveryNo statement from Department of Health NI found
Recommendation, verbatim from the inquiry
●Inquiry recommendation
The Department of Health (Northern Ireland) should reconstitute the role of the Chief Medical Officer for Northern Ireland as an independent advisory role. The Chief Medical Officer for Northern Ireland should not have managerial responsibilities within the Department of Health (Northern Ireland).
COVID-19 Inquiry, Module 2: Core Decision-Making · 20 Nov 2025 Source PDF →
Published evidence summary
AI-generated evidence summary
In March 2026, the Northern Ireland Executive accepted the recommendation, stating that following departmental restructuring the Chief Medical Officer no longer held managerial responsibility for departmental directorates, though further options to safeguard the role's independent advisory status were being developed before establishing an implementation timeframe (Northern Ireland Executive response, Mar 2026). The record holds no update since the Northern Ireland Executive's response of March 2026 (Northern Ireland Executive response, Mar 2026).
Sources
AI-generated summary of the record on this page, checked by a second model and automatic checks, 26 Sep 2026.
Government response
●UK Government · Not applicable · 25 Mar 2026
This recommendation is not for the UK government to respond to.
Extract from: UK Government Response to the Covid-19 Inquiry Module 2 Report
●Northern Ireland Executive · Accepted · 18 Mar 2026
Accepted
Following restructuring of the Department of Health in November 2023, the Population Health Directorate, the Health Protection Directorate, the Emergency Planning Resilience and Response Directorate and the Quality, Safety and Improvement Directorate were moved out of the Chief Medical Officer’s Group. Responsibility for these Directorates now lies within other Groups in the Department. The Chief Medical Officer continues to provide professional expert technical advice to the relevant policy teams but no longer holds managerial responsibility for these Directorates.
Building on the remit and managerial changes already implemented within the Chief Medical Officer’s Group, the Department of Health is developing further options to enhance and safeguard the independence of the Chief Medical Officer’s advisory role, which will be discussed with the Permanent Secretary. Once a decision on next steps has been made, a timeframe for implementation will be developed.
Professor Helen McCarthy was appointed as the first Chief Scientific and Technology Adviser (CSTA) for here in June 2024. The CSTA operates across all NI Departments, co-ordinating with existing departmental science advisers in Health and the Department of Agriculture, Environment and Rural Affairs (DAERA). The role also includes providing advice to Ministers and serving as Head of Profession for the scientific community within the Northern Ireland Civil Service. CSTA also chairs the NI Science & Technology Network, co-ordinates the regional research strategy and represents NI in scientific forums across the UK, Europe and globally.
Extract from: Executive Response to the Covid-19 Module 2 Report March 2026
Delivery
No statement on delivery from Department of Health NI has been found in the sources searched. This is separate from the response above.
How this page is built
The recommendation and the government responses are verbatim from primary documents. Delivery statements and other bodies' findings are shown in their own words, each with its source. The summary is written by this site and labelled as such. The Index does not paraphrase sources or characterise intent; it records what has been published.